The Food and Drug Administration () is set to approve vaccine booster shots for children as young as five years old as early as Tuesday, the New York Times .The Pfizer-BioNTech vaccine will likely receive the approval this week, becoming the first booster shot children as young as five are eligible for. 's jab is already the only one available to minors in the U.S. - with children as young as five eligible for the first two-dose regimen - and its booster eligibility will now match that of its initial doses.
Load More
Load More